Management of acquired resistance to ALK inhibitors: Repeat biopsy to characterize mechanisms of resistance does not significantly impact clinical outcomes

Naiyarat PrasongsookThanyanan ReungwetwattanaRamathibodi HospitalPhramongkutklao College of Medicine2022-08-042022-08-042021-03-01Precision Cancer Medicine. Vol.4, No.March (2021)261722162-s2.0-85110627470https://repository.li.mahidol.ac.th/handle/123456789/76252Mahidol UniversityBiochemistry, Genetics and Molecular BiologyMedicineNursingManagement of acquired resistance to ALK inhibitors: Repeat biopsy to characterize mechanisms of resistance does not significantly impact clinical outcomesNoteSCOPUS10.21037/pcm-2020-mnsclc-09